NEW ‘QIPP & EMOLLIENTS’ TOOL KIT COULD SAVE NHS £12m


NHS England spends £102 million p.a. on emollients [1] – by changing from proprietary emollient brands to the cost effective Zeroderma range of emollients, the NHS could save £12 million p.a. in England alone[1]. A new QIPP & emollients tool kit has been developed by Medicines Management teams which contains everything


needed to implement product changes at practice level, plus a cost savings calculator to calculate how much each region could save.


The QIPP toolkit has been designed to enable a smooth and easy implementation process which maximises cost savings at practice level without compromising on patient care. It includes:


• Tried and tested practice support materials and adaptable templates for easy implementation at practice level


• Details of potential cost savings for your area – the Zeroderma range can offer up to 41% savings against equivalent emollient brands without compromising on patient care


• A case study from one NHS Trust who has implemented such changes at practice level and is on track to save £250,000 on emollients


Visit us on Stand H62 at


The Commissioning Show (12-13 June, Excel, London)


zeroderma@thorntonross.com www.qipp.trderma.co.uk 01484 842217


For further information:


A Northern based NHS Trust who has implemented the changes and provided input into the toolkit said: “The product switch was very well received by GPs and patients, who are both highly positive about the change as it had no negative impact on care. This new QIPP & emollients tool kit provides the templates and practice support tools to make the change quickly and easily. However, it is not sufficient to just add products to the formulary, change needs to be steered through to ensure prescribing practices are altered at practice level to deliver cost and quality improvements in emollient prescribing.”


References 1. The annual total emollient spend for NHS England during the 12months ending Sept 2012 was £102m(NHSBSA 2012). Of this 34%could be substituted with the Zeroderma range of emollients, meaning that NHS England could save over £12mwith the Zeroderma range.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72